ELV vs. ABBV
Compare and contrast key facts about Elevance Health Inc (ELV) and AbbVie Inc. (ABBV).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ELV or ABBV.
Correlation
The correlation between ELV and ABBV is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
ELV vs. ABBV - Performance Comparison
Loading data...
Key characteristics
ELV:
-0.87
ABBV:
0.71
ELV:
-1.08
ABBV:
0.97
ELV:
0.86
ABBV:
1.15
ELV:
-0.68
ABBV:
0.85
ELV:
-1.13
ABBV:
2.09
ELV:
20.84%
ABBV:
8.49%
ELV:
27.49%
ABBV:
27.46%
ELV:
-67.19%
ABBV:
-45.09%
ELV:
-27.23%
ABBV:
-14.01%
Fundamentals
ELV:
$93.17B
ABBV:
$328.29B
ELV:
$25.69
ABBV:
$2.34
ELV:
15.75
ABBV:
78.89
ELV:
0.74
ABBV:
0.39
ELV:
0.51
ABBV:
5.72
ELV:
2.19
ABBV:
229.63
ELV:
$183.12B
ABBV:
$57.37B
ELV:
$114.62B
ABBV:
$44.44B
ELV:
$10.09B
ABBV:
$16.33B
Returns By Period
In the year-to-date period, ELV achieves a 10.13% return, which is significantly higher than ABBV's 5.83% return. Over the past 10 years, ELV has underperformed ABBV with an annualized return of 11.34%, while ABBV has yielded a comparatively higher 15.72% annualized return.
ELV
10.13%
-7.29%
-3.47%
-23.88%
9.63%
11.34%
ABBV
5.83%
6.95%
-5.73%
19.02%
20.92%
15.72%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ELV vs. ABBV — Risk-Adjusted Performance Rank
ELV
ABBV
ELV vs. ABBV - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Elevance Health Inc (ELV) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
ELV vs. ABBV - Dividend Comparison
ELV's dividend yield for the trailing twelve months is around 1.63%, less than ABBV's 3.46% yield.
TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
ELV Elevance Health Inc | 1.63% | 1.77% | 1.26% | 1.00% | 0.98% | 1.18% | 1.06% | 1.14% | 1.20% | 1.81% | 1.79% | 1.39% |
ABBV AbbVie Inc. | 3.46% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% | 2.54% |
Drawdowns
ELV vs. ABBV - Drawdown Comparison
The maximum ELV drawdown since its inception was -67.19%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for ELV and ABBV. For additional features, visit the drawdowns tool.
Loading data...
Volatility
ELV vs. ABBV - Volatility Comparison
The current volatility for Elevance Health Inc (ELV) is 8.07%, while AbbVie Inc. (ABBV) has a volatility of 9.90%. This indicates that ELV experiences smaller price fluctuations and is considered to be less risky than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
ELV vs. ABBV - Financials Comparison
This section allows you to compare key financial metrics between Elevance Health Inc and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ELV vs. ABBV - Profitability Comparison
ELV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Elevance Health Inc reported a gross profit of 43.91B and revenue of 48.89B. Therefore, the gross margin over that period was 89.8%.
ABBV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported a gross profit of 11.20B and revenue of 13.34B. Therefore, the gross margin over that period was 83.9%.
ELV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Elevance Health Inc reported an operating income of 3.14B and revenue of 48.89B, resulting in an operating margin of 6.4%.
ABBV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported an operating income of 3.73B and revenue of 13.34B, resulting in an operating margin of 28.0%.
ELV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Elevance Health Inc reported a net income of 2.18B and revenue of 48.89B, resulting in a net margin of 4.5%.
ABBV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported a net income of 1.29B and revenue of 13.34B, resulting in a net margin of 9.6%.
ELV vs. ABBV - Valuation Comparison
ELV - PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for ELV, comparing it with other companies in the Healthcare Plans industry. Currently, ELV has a P/E ratio of 15.7. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
ABBV - PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for ABBV, comparing it with other companies in the Drug Manufacturers - General industry. Currently, ABBV has a P/E ratio of 78.9. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.
ELV - PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for ELV compared to other companies in the Healthcare Plans industry. ELV currently has a PEG ratio of 0.7. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.
ABBV - PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for ABBV compared to other companies in the Drug Manufacturers - General industry. ABBV currently has a PEG ratio of 0.4. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.
ELV - PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for ELV relative to other companies in the Healthcare Plans industry. Currently, ELV has a P/S ratio of 0.5. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
ABBV - PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for ABBV relative to other companies in the Drug Manufacturers - General industry. Currently, ABBV has a P/S ratio of 5.7. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
ELV - PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for ELV in comparison with other companies in the Healthcare Plans industry. Currently, ELV has a P/B value of 2.2. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
ABBV - PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for ABBV in comparison with other companies in the Drug Manufacturers - General industry. Currently, ABBV has a P/B value of 229.6. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
User Portfolios with ELV or ABBV
Recent discussions
calculation of performance
Portfolio performance graph for past 1Y (thru 3/13/2025):
GLD=37.82%
IAU=37.97%
IAUM=38.34%
using daily adjusted closing market price (from NASDAQ) integrating the logarithmic daily rate of return between 3/13/2025 to 3/14/2025 to calculate the cumulative rate of return, I calculate
GLD=31.34%
IAU=31.45%
IAUM=31.66%
These ETF's do not pay a dividend, Expense cost is included in the closing price.
The difference in rate of return is about 6%, which is too large. I can send you my calculation (xls) if this would be useful.
What is causing the error?
Marcus Crahan
Does Portfolio Performance Consider Historical Composition?
When I see the past performance of a particular portfolio, does it mean the performance of the current composition, or do I get the performance by weighting the portfolio against all its old compositions?
It is very important to learn about the success of the portfolio.
MOTTY
Market filter for screeners
Scott Allen